Oya, Y.; Kuroda, H.; Nakada, T.; Takahashi, Y.; Sakakura, N.; Hida, T.
Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement. Int. J. Mol. Sci. 2020, 21, 2623.
https://doi.org/10.3390/ijms21072623
AMA Style
Oya Y, Kuroda H, Nakada T, Takahashi Y, Sakakura N, Hida T.
Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement. International Journal of Molecular Sciences. 2020; 21(7):2623.
https://doi.org/10.3390/ijms21072623
Chicago/Turabian Style
Oya, Yuko, Hiroaki Kuroda, Takeo Nakada, Yusuke Takahashi, Noriaki Sakakura, and Toyoaki Hida.
2020. "Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement" International Journal of Molecular Sciences 21, no. 7: 2623.
https://doi.org/10.3390/ijms21072623
APA Style
Oya, Y., Kuroda, H., Nakada, T., Takahashi, Y., Sakakura, N., & Hida, T.
(2020). Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement. International Journal of Molecular Sciences, 21(7), 2623.
https://doi.org/10.3390/ijms21072623